How Quality Systems Change Across Gummies, Powders, Capsules, Softgels and Liquids

Dietary supplement CGMP principles apply across dosage forms, but the critical process controls and failure modes are not identical.

A powder can segregate. A capsule can drift in fill weight. A gummy can change during heating, depositing, and drying. A softgel can leak or develop shell-fill interactions. A liquid can separate or support microbial growth if its control system fails.

A strong multi-format manufacturer uses one disciplined quality system while building product-specific specifications, sampling, methods, process controls, and stability programs for each format.

Quick Answer

One Quality System, Different Critical Controls

Across all formats, verify:

  • Supplier and raw-material qualification

  • Identity and specification controls

  • Master manufacturing and batch records

  • Equipment, sanitation, and environmental controls

  • In-process checks

  • Representative finished sampling

  • Scientifically valid methods

  • Batch review and release

  • Deviations, complaints, and change control

  • Stability in the intended package

Then ask which format-specific attributes can cause dose, safety, physical, or shelf-life failure.

Common Quality Foundation

CGMP Is Not Format-Blind, but It Is Systematic

Under 21 CFR Part 111, manufacturers must establish specifications and production and process controls designed to ensure the quality of the dietary supplement.

The same broad framework applies to gummies, powders, capsules, softgels, and liquids. However, the selected controls should reflect the product's components, process, equipment, risks, specifications, and intended use.

A generic “GMP checklist” cannot replace a product-specific control plan.

Gummies

Control a Heated, Deposited, Conditioned Matrix

Important gummy controls can include:

  • Hydrocolloid and solids preparation

  • pH and acid addition

  • Time-temperature exposure

  • Active dispersion or emulsion

  • Slurry viscosity and hold time

  • Depositor accuracy and unit weight

  • Setting, drying, and conditioning

  • Moisture and water activity

  • Texture, sticking, and coating

  • Finished potency and stability

Beginning-middle-end samples can identify settling or process drift. The launch package should be evaluated for humidity and heat sensitivity.

Powders

Control Flow, Blend, Moisture, and Fill

Powder quality depends on particle properties and handling. Key risks include segregation, poor flow, dusting, moisture uptake, electrostatic effects, and inaccurate scoop or sachet delivery.

Controls may include:

  • Particle size and bulk density

  • Sieving and foreign-material control

  • Preblend strategy for low-dose components

  • Blender type, fill, time, and sequence

  • Blend-uniformity sampling

  • Transfer and segregation control

  • Fill or net-weight checks

  • Moisture and package seal

A uniform blender sample does not guarantee that the material remains uniform through transfer and filling.

Capsules

Control Shell, Flow, and Fill-Weight Distribution

Capsules require a powder or granular fill that flows consistently into the shell. Low-dose actives can challenge blend uniformity, while high-dose formulas may exceed the selected capsule size.

Review:

  • Capsule shell identity and storage

  • Fill material flow and density

  • Blend uniformity

  • Encapsulation speed and settings

  • Average and individual fill weights

  • Appearance and closure

  • Disintegration where applicable

  • Moisture compatibility between shell and fill

Unit weight and potency should be interpreted together.

Softgels

Control the Fill and the Shell as an Interacting System

Softgels combine an oil, suspension, or other fill with a gelatin or alternative shell. Fill components can migrate into the shell, and shell moisture can affect the fill.

Controls can include:

  • Fill identity, assay, particle size, and homogeneity

  • Suspension agitation

  • Gel mass preparation

  • Ribbon thickness

  • Seam formation and fill weight

  • Drying conditions

  • Leakage and visual defects

  • Shell moisture and disintegration

  • Oxidation and package protection

The commercial specification should distinguish fill-related and shell-related attributes.

Liquids

Control Homogeneity, Microbiology, and Container Delivery

Liquids may be solutions, emulsions, or suspensions. Key risks include separation, sedimentation, oxidation, flavor change, microbial growth, and inaccurate dose delivery.

Review:

  • Water quality

  • Mixing and order of addition

  • pH and preservative system where applicable

  • Homogeneity and particle suspension

  • Viscosity

  • Fill volume

  • Closure and tamper evidence

  • Dropper, cup, pump, or spoon dose accuracy

  • Microbiological and stability controls

Instructions such as “shake well” do not replace a controlled formulation and verified delivered dose.

Raw-Material Differences

The Same Active Can Need Different Grades

An ingredient suitable for a powder may not suit a gummy, liquid, or softgel. Solubility, particle size, oil compatibility, taste, heat sensitivity, moisture, density, and carrier matter.

Qualification should identify the intended dosage form and process. Changing grade or supplier can require new mixing, method, sensory, and stability evaluation.

In-Process Sampling

Sample Where Failure Can Occur

Sampling should reflect process flow.

  • Gummies: vessel plus beginning-middle-end units

  • Powders: blender locations plus filling stages

  • Capsules: periodic unit weights and representative composites

  • Softgels: fill tank, seam and weight checks, drying stages

  • Liquids: vessel locations, fill stages, and delivered-dose checks

The plan should state what decision each sample supports.

Finished Potency

Matrix-Suitable Methods Are Essential

The same active can require different sample preparation across a gummy, powder, capsule, softgel, or liquid.

Hydrocolloids, fats, proteins, flavors, colors, fibers, shell materials, emulsifiers, and suspended particles may affect extraction or interference.

Review method suitability, recovery, precision, units, sampling, and conversion to serving. Do not assume one raw-material method is universal across formats.

Physical Specifications

Appearance Is Not Enough

Format-specific physical attributes support function and consumer use:

  • Gummies: unit weight, dimensions, texture, moisture, water activity

  • Powders: flow, bulk density, particle size, net weight

  • Capsules: shell integrity, fill weight, disintegration

  • Softgels: seam, leakage, fill weight, shell moisture

  • Liquids: pH, viscosity, fill volume, separation, delivered dose

Define objective limits or controlled reference standards where appropriate.

Microbiological Control

Water and Process Exposure Change Risk

Low-water-activity powders can still carry microbial contamination. Gummies and soft chews require sanitation and controlled conditioning. Liquids may require stronger formulation and process controls depending on pH, water activity, preservatives, and handling.

Select limits, sampling, environmental practices, water controls, and methods based on product risk and market requirements.

Packaging

Each Format Has a Different Protection Need

Gummies may need humidity and heat protection. Powders and effervescents may be moisture-sensitive. Capsules can become brittle or soft. Softgels may need oxygen and leak protection. Liquids need closure integrity and compatible delivery devices.

Package specifications, line checks, seal verification, transport, and stability should match the format.

Stability

Follow the Failure Mode That Matters

Potency is only one shelf-life attribute.

Monitor relevant physical and chemical changes, such as gummy texture, powder caking, capsule shell condition, softgel leakage or oxidation, and liquid separation or microbial quality.

Use the intended package and define time points, conditions, methods, acceptance criteria, and trend review. Accelerated studies identify risk; real-time data support shelf-life conclusions.

Multi-Format Change Control

A Format Conversion Is a New Development Project

Moving an active from capsule to gummy or powder to liquid changes excipients, exposure, method, package, serving, and risks.

Do not transfer the old formula, specification, method, or shelf life without impact assessment. Establish a new product record and controlled development path.

Manufacturer Evaluation Questions

  1. Which critical attributes are defined for each format?

  2. How are low-dose and suspended actives sampled?

  3. Which methods are verified for each matrix?

  4. How are unit or fill weights trended?

  5. What environmental and water controls apply?

  6. How is package integrity checked?

  7. Which stability attributes are format-specific?

  8. How are transfers between formats controlled?

Red Flags

  • One generic specification is used across formats

  • The same sampling plan is copied to every process

  • A raw-material method is assumed to fit all matrices

  • Physical quality is evaluated only visually

  • Package selection is separated from stability

  • “Shake well” substitutes for liquid-dose verification

  • Softgel shell and fill are not evaluated together

  • Format conversion is treated as a packaging change

How VitaMFG Manages Multi-Format Quality

Apply Common Discipline to Product-Specific Risk

VitaMFG connects the product brief, raw materials, dosage form, process, in-process controls, finished specifications, methods, packaging, and stability.

The quality framework remains consistent while the control plan changes by format. For gummies, powders, capsules, softgels, liquids, and soft chews, testing and sampling are selected around the actual matrix and commercial process.

Frequently Asked Questions

Does one GMP certificate cover every product format equally?

It supports the facility quality system within its scope. The brand should still verify that the site, activities, equipment, and controls are suitable for the specific format.

Can the same potency method be used across formats?

Possibly, but suitability must be demonstrated for each relevant matrix and preparation.

Which format is easiest to control?

No format is risk-free. Complexity depends on dose, ingredients, process, package, method, and shelf-life requirements.

Is finished testing enough?

No. Finished testing samples only part of a lot. It must work with supplier qualification, process controls, records, and quality review.

Final Recommendation

Evaluate multi-format manufacturing through both system consistency and format-specific evidence.

The manufacturer should apply disciplined CGMP controls across the facility while defining the distinct process, sampling, methods, physical specifications, packaging, and stability needs of every dosage form.

VitaMFG can review the manufacturing and quality requirements for a single-format or multi-format supplement platform.

  • Electronic Code of Federal Regulations: 21 CFR Part 111 — https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111

  • FDA: Current Good Manufacturing Practice for Dietary Supplements — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practices-manufacturing-packaging-labeling-or-holding-operations-dietary-supplements

  • NSF: NSF/ANSI 455-2 Good Manufacturing Practices for Dietary Supplements — https://www.nsf.org/knowledge-library/nsf-ansi-455-2-good-manufacturing-practices-gmps-for-dietary-supplements